AHEALTH | APEX HEALTHCARE BERHAD

99
3.15 (-2.48%)

T-O: 3.2 (08:59:00)
Last updated: 10:10

Fundamental
Technical
Total Score

AHEALTH | APEX HEALTHCARE BERHAD

iSaham Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Quarter Reports

Chart:

Trailing Dividend

Financial Ratios

EPS15.5 sen
Trailing PE (Sector Median: 16.9)20.3
PEG0.2
Altman Z2.8
Beaver0.131
Current Ratio2.77
Debt-Equity (DE) Ratio0.34
FCF Yield-0.11 %
Revenue QoQ14.62 %
Revenue YoY20.38 %
Profit QoQ83.15 %
Profit YoY38.73 %
Profit Margin (Sector Median: 7.2)8.87 %
ROE (ROIC: 14.46)14.65 %
Dividend Per Share (DPS)12.0 sen
Dividend Yield (DY)3.82 %

Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Average Analysts FV based on 3 rating(s)
Graham Formula
Graham Number
Net Tangible Asset (NTA)1.06
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M]23.49
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M)250.22
Expected Revenue (M)3199.73
Expected Growth (%)26.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

Directors Share Purchases (Beta)


MR KEE KIRK CHUEN added 30000.0 units announced on 14 Jul 2022 at ~RM2.92

MR ROBERT DOBSON MILLNER added 44000.0 units announced on 12 Jul 2022 at ~RM2.92

DR KEE KIRK CHIN added 152000.0 units announced on 12 Jul 2022 at ~RM2.92

MR KEE KIRK CHUEN added 152000.0 units announced on 12 Jul 2022 at ~RM2.92

MR ROBERT DOBSON MILLNER added 76000.0 units announced on 08 Jul 2022 at ~RM2.9

MR ROBERT DOBSON MILLNER added 80000.0 units announced on 07 Jul 2022 at ~RM2.85

MR KEE KIRK CHUEN added 10000.0 units announced on 04 Jan 2022 at ~RM2.55

DR KEE KIRK CHIN added 10000.0 units announced on 04 Jan 2022 at ~RM2.55

MR KEE KIRK CHUEN added 30000.0 units announced on 13 Dec 2021 at ~RM2.57

DR KEE KIRK CHIN added 1000000.0 units announced on 11 Jun 2021 at ~RM2.9

MR KEE KIRK CHUEN added 1000000.0 units announced on 11 Jun 2021 at ~RM2.9

MR KEE KIRK CHUEN added 74000.0 units announced on 25 May 2021 at ~RM2.89

DR KEE KIRK CHIN added 74000.0 units announced on 25 May 2021 at ~RM2.89

DR KEE KIRK CHIN added 58000.0 units announced on 24 May 2021 at ~RM2.83

MR KEE KIRK CHUEN added 58000.0 units announced on 24 May 2021 at ~RM2.83

MR KEE KIRK CHUEN added 50000.0 units announced on 12 Mar 2021 at ~RM2.87

MR KEE KIRK CHUEN added 104000.0 units announced on 26 Jan 2021 at ~RM3.35

DR KEE KIRK CHIN added 104000.0 units announced on 26 Jan 2021 at ~RM3.35

Summary


Market Cap: 1498 M.

Number of Shares: 477 M.

Adjusted Float: 30.3%.

Stock highly correlated with

LKL (82%)

JIANKUN (80%)

PASUKGB (80%)

G3 (79%)

Apex Healthcare Berhad is an investment holding company. The company is engaged in the development, manufacturing, wholesaling, marketing, and distribution of pharmaceuticals, consumer healthcare products, and medical devices. For example range of products in the manufacturing segment include cough mixtures and antihistamines, anti-infectives, anti-diabetics, anti-hypertensives, neuromuscular agents, analgesics, dermatological and ophthalmological in the form of tablets, capsules, oral liquid, and suspension, creams, and sterile eyedrops. The company is also one of the distributors for internationally famous brands such as Nestle, 3M, and Rigel Pharma. It has direct operations in Malaysia, Singapore, Vietnam, and Myanmar. The company was founded in 1962 and is headquartered in Melaka, Malaysia.

Sectors: Pharmaceuticals, Healthcare, Vaccine

Code: 7090

Website: http://www.apexhealthcare.com.my/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

Top Shareholdings

Updated on 15-Mar-2022

ShareholderValue (M)
Apex Pharmacy Holdings Sendirian Berhad599.36
Washington H.Soul Pattinson and Company Limited446.79
Lim Teh Realty Sdn Berhad20.4
Md Ali Bin Md Dewal15.45
Liew Yoon Yee13.2
Xepa Holdings Sdn. Bhd.13.05
Public Islamic Opportunities Fund12.6
Tan Yan Meng Warren12.6
DBS Bank Ltd12.0
Apex Holdings (Pte) Ltd8.1
Employees Provident Fund Board8.1
Chan Heng Koon7.8
Teoh Choon Neo @ Ivy Teoh Choon Neo7.2
Public Focus Select Fund7.2
Manulife Investment Progress Fund7.05
Singam A/L Kumarasamy6.9
PB Islamic Smallcap Fund6.6
ICapital.Biz Berhad6.45
Yeo Lee Hee5.85
Rastam Dewal Bin Md Ali5.7
Oh Siew Heong5.1
Wong Yee Hui5.1
Tan Jin Thai4.8
Kee Kirk Chin4.2
Leong Wai Kuen3.9
Susy Ding3.9
Phua Kiap Wite3.6
Lim Khuan Eng3.45

This calculator use Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator use Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.